Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 78

1.

MicroRNA expression, survival, and response to interferon in liver cancer.

Ji J, Shi J, Budhu A, Yu Z, Forgues M, Roessler S, Ambs S, Chen Y, Meltzer PS, Croce CM, Qin LX, Man K, Lo CM, Lee J, Ng IO, Fan J, Tang ZY, Sun HC, Wang XW.

N Engl J Med. 2009 Oct 8;361(15):1437-47. doi: 10.1056/NEJMoa0901282.

2.

Development of a miR-26 companion diagnostic test for adjuvant interferon-alpha therapy in hepatocellular carcinoma.

Ji J, Yu L, Yu Z, Forgues M, Uenishi T, Kubo S, Wakasa K, Zhou J, Fan J, Tang ZY, Fu S, Zhu H, Jin JG, Sun HC, Wang XW.

Int J Biol Sci. 2013;9(3):303-12. doi: 10.7150/ijbs.6214. Epub 2013 Mar 16.

3.
4.

Underexpressed microRNA-199b-5p targets hypoxia-inducible factor-1α in hepatocellular carcinoma and predicts prognosis of hepatocellular carcinoma patients.

Wang C, Song B, Song W, Liu J, Sun A, Wu D, Yu H, Lian J, Chen L, Han J.

J Gastroenterol Hepatol. 2011 Nov;26(11):1630-7. doi: 10.1111/j.1440-1746.2011.06758.x.

PMID:
21557766
6.

MicroRNA-26b suppresses the NF-κB signaling and enhances the chemosensitivity of hepatocellular carcinoma cells by targeting TAK1 and TAB3.

Zhao N, Wang R, Zhou L, Zhu Y, Gong J, Zhuang SM.

Mol Cancer. 2014 Feb 24;13:35. doi: 10.1186/1476-4598-13-35.

7.

Upregulation of microRNA-25 associates with prognosis in hepatocellular carcinoma.

Su ZX, Zhao J, Rong ZH, Geng WM, Wu YG, Qin CK.

Diagn Pathol. 2014 Mar 4;9:47. doi: 10.1186/1746-1596-9-47.

8.

Interferon therapy for hepatocellular carcinoma patients with low HCV-RNA levels.

Miyaguchi S, Watanabe T, Takahashi H, Nakamura M, Saito H, Ishii H.

Hepatogastroenterology. 2002 May-Jun;49(45):724-9.

PMID:
12063979
9.

Downregulation of MicroRNA-1 is Associated with Poor Prognosis in Hepatocellular Carcinoma.

Wang X, Huang Y, Zhuang H, Qian Y, Zhao Q, Yang L, Gu H, Chen J, Guo R, Liu Y.

Clin Lab. 2015;61(9):1331-6.

PMID:
26554254
10.

MicroRNA-21 induces resistance to the anti-tumour effect of interferon-α/5-fluorouracil in hepatocellular carcinoma cells.

Tomimaru Y, Eguchi H, Nagano H, Wada H, Tomokuni A, Kobayashi S, Marubashi S, Takeda Y, Tanemura M, Umeshita K, Doki Y, Mori M.

Br J Cancer. 2010 Nov 9;103(10):1617-26. doi: 10.1038/sj.bjc.6605958. Epub 2010 Oct 26.

11.

Identification of recurrence-related microRNAs in hepatocellular carcinoma following liver transplantation.

Han ZB, Zhong L, Teng MJ, Fan JW, Tang HM, Wu JY, Chen HY, Wang ZW, Qiu GQ, Peng ZH.

Mol Oncol. 2012 Aug;6(4):445-57. doi: 10.1016/j.molonc.2012.04.001. Epub 2012 Apr 17.

12.

MicroRNA profiling in hepatocellular tumors is associated with clinical features and oncogene/tumor suppressor gene mutations.

Ladeiro Y, Couchy G, Balabaud C, Bioulac-Sage P, Pelletier L, Rebouissou S, Zucman-Rossi J.

Hepatology. 2008 Jun;47(6):1955-63. doi: 10.1002/hep.22256.

13.

Interferon therapy after tumor ablation improves prognosis in patients with hepatocellular carcinoma associated with hepatitis C virus.

Shiratori Y, Shiina S, Teratani T, Imamura M, Obi S, Sato S, Koike Y, Yoshida H, Omata M.

Ann Intern Med. 2003 Feb 18;138(4):299-306.

PMID:
12585827
14.

MicroRNA gene expression profile of hepatitis C virus-associated hepatocellular carcinoma.

Varnholt H, Drebber U, Schulze F, Wedemeyer I, Schirmacher P, Dienes HP, Odenthal M.

Hepatology. 2008 Apr;47(4):1223-32. doi: 10.1002/hep.22158.

PMID:
18307259
15.

MicroRNA expression profiles associated with prognosis and therapeutic outcome in colon adenocarcinoma.

Schetter AJ, Leung SY, Sohn JJ, Zanetti KA, Bowman ED, Yanaihara N, Yuen ST, Chan TL, Kwong DL, Au GK, Liu CG, Calin GA, Croce CM, Harris CC.

JAMA. 2008 Jan 30;299(4):425-36. doi: 10.1001/jama.299.4.425.

16.

Serum microRNA-1 and microRNA-122 are prognostic markers in patients with hepatocellular carcinoma.

Köberle V, Kronenberger B, Pleli T, Trojan J, Imelmann E, Peveling-Oberhag J, Welker MW, Elhendawy M, Zeuzem S, Piiper A, Waidmann O.

Eur J Cancer. 2013 Nov;49(16):3442-9. doi: 10.1016/j.ejca.2013.06.002. Epub 2013 Jun 26.

PMID:
23810247
17.

A Seven-microRNA Expression Signature Predicts Survival in Hepatocellular Carcinoma.

Zhang J, Chong CC, Chen GG, Lai PB.

PLoS One. 2015 Jun 5;10(6):e0128628. doi: 10.1371/journal.pone.0128628. eCollection 2015.

18.

A randomized, controlled trial of postoperative adjuvant interferon therapy after resection of hepatocellular carcinoma.

Lo CM, Liu CL, Chan SC, Lam CM, Poon RT, Ng IO, Fan ST, Wong J.

Ann Surg. 2007 Jun;245(6):831-42.

19.

[Bioinformatics on vascular invasion markers in hepatocellular carcinoma via Big-Data analysis].

Chen Q, Qiu XQ.

Zhonghua Liu Xing Bing Xue Za Zhi. 2017 Apr 10;38(4):522-527. doi: 10.3760/cma.j.issn.0254-6450.2017.04.022. Chinese.

PMID:
28468075
20.

Comprehensive profiling of novel microRNA-9 targets and a tumor suppressor role of microRNA-9 via targeting IGF2BP1 in hepatocellular carcinoma.

Zhang J, Cheng J, Zeng Z, Wang Y, Li X, Xie Q, Jia J, Yan Y, Guo Z, Gao J, Yao M, Chen X, Lu F.

Oncotarget. 2015 Dec 8;6(39):42040-52. doi: 10.18632/oncotarget.5969.

Supplemental Content

Support Center